Olympus to Acquire Quest Photonic Devices
Olympus Corp. is acquiring Quest Photonic Devices BV, a developer of multispectral imaging solutions serving medical markets. The deal is worth up to approximately $60.7 million (€50 million).
Olympus, in a press release, said the planned acquisition enhances its surgical endoscopy market presence. Quest offers advanced fluorescence imaging systems for the medical field, enabling more surgical endoscopy capabilities compared to conventional imaging technologies.
Fluorescence imaging refers to special light imaging technologies that use the properties of fluorescent dyes directed to specific anatomical structures. When targeted dyes combine with specific light wavelengths, lesions that are nearly invisible under normal white light become visible.
LATEST NEWS
- CLEO Heads to the East Coast
Apr 29, 2024
- Laser-Based Gas Analyzer Developed to Detect Air Pollution
Apr 29, 2024
- Qubits Could be Stored in Flash-Like Memory
Apr 29, 2024
- Exail Signs LLNL Contract, Partners with Eelume
Apr 26, 2024
- Menlo Moves U.S. HQ: Week in Brief: 4/26/2024
Apr 26, 2024
- Optofluidics Platform Keys Label-, Amplification-Free Rapid Diagnostic Tool
Apr 25, 2024
- DUV Lasers Made with Nonlinear Crystals Enhance Lithography Performance
Apr 25, 2024
- Teledyne e2v, Airy3D Collaborate on 3D Vision Solutions
Apr 24, 2024